Connection

RITSUKO KOMAKI to Receptors, Tumor Necrosis Factor, Type II

This is a "connection" page, showing publications RITSUKO KOMAKI has written about Receptors, Tumor Necrosis Factor, Type II.
  1. TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy. BMC Cancer. 2011 Oct 14; 11:447.
    View in: PubMed
    Score: 0.098
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.